Carl H June Selected Research

Carl H June Research Topics

Disease

180	Neoplasms (Cancer) 05/2024 - 02/2002
31	Hematologic Neoplasms (Hematological Malignancy) 02/2024 - 11/2006
29	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 02/2024 - 04/2013
24	Leukemia 01/2023 - 03/2008
20	Cytokine Release Syndrome 02/2024 - 04/2013
16	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 03/2024 - 08/2011
15	Ovarian Neoplasms (Ovarian Cancer) 10/2023 - 04/2003
13	Lymphoma (Lymphomas) 05/2024 - 03/2008
13	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2017 - 12/2004
11	Multiple Myeloma 08/2023 - 01/2011
11	Infections 01/2021 - 01/2002
10	HIV Infections (HIV Infection) 01/2016 - 01/2002
8	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2023 - 10/2009
7	Breast Neoplasms (Breast Cancer) 01/2023 - 03/2005
7	Glioblastoma (Glioblastoma Multiforme) 01/2021 - 02/2015
5	Adenocarcinoma 01/2023 - 01/2016
5	Melanoma (Melanoma, Malignant) 01/2023 - 05/2003
5	Carcinoma (Carcinomatosis) 11/2019 - 03/2005
5	Communicable Diseases (Infectious Diseases) 01/2019 - 02/2002
4	Bites and Stings (Sting) 05/2024 - 01/2017
4	B-Cell Lymphoma (Lymphoma, B Cell) 01/2024 - 12/2017
4	Persistent Infection 07/2023 - 02/2007
4	Pancreatic Neoplasms (Pancreatic Cancer) 12/2021 - 01/2018
4	Neuroblastoma 09/2020 - 12/2012
4	Inflammation (Inflammations) 01/2019 - 10/2009
4	Testicular Neoplasms (Testicular Cancer) 01/2016 - 04/2013
4	Mesothelioma 06/2013 - 03/2005
3	cell-associated neurotoxicity 03/2024 - 01/2022
3	Residual Neoplasm 02/2024 - 01/2023
3	Fibrosis (Cirrhosis) 07/2023 - 01/2019
3	Sepsis (Septicemia) 01/2022 - 11/2019
3	Prostatic Neoplasms (Prostate Cancer) 01/2022 - 01/2018
3	Critical Illness (Critically Ill) 10/2020 - 01/2016
3	Malignant Mesothelioma 11/2019 - 04/2010
3	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 12/2018 - 12/2017
3	Body Weight (Weight, Body) 10/2014 - 08/2011
3	Lymphopenia (Lymphocytopenia) 12/2012 - 11/2005
2	T-Cell Lymphoma (Lymphoma, T Cell) 01/2024 - 01/2023
2	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL) 01/2023 - 01/2023
2	Autoimmune Diseases (Autoimmune Disease) 11/2022 - 01/2017
2	Neoplasm Metastasis (Metastasis) 01/2022 - 01/2018
2	COVID-19 01/2022 - 01/2020
2	Brain Neoplasms (Brain Tumor) 01/2019 - 07/2017
2	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 12/2018 - 12/2017
2	Disease Progression 11/2018 - 01/2002
2	Hodgkin Disease (Hodgkin's Disease) 01/2018 - 10/2017

Drug/Important Bio-Agent (IBA)

136	Chimeric Antigen ReceptorsIBA 05/2024 - 03/2008
48	AntigensIBA 01/2024 - 11/2002
27	CytokinesIBA 05/2024 - 01/2002
20	tisagenlecleucelIBA 02/2024 - 04/2013
18	MesothelinIBA 08/2023 - 03/2009
14	Proteins (Proteins, Gene)FDA Link 08/2023 - 11/2002
11	Neoplasm Antigens (Tumor Antigens)IBA 08/2023 - 01/2003
10	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2022 - 08/2011
9	VaccinesIBA 10/2023 - 06/2007
8	Messenger RNA (mRNA)IBA 02/2024 - 11/2010
8	bis(3- bis(4- chlorophenyl)methyl- 4- dimethylaminophenyl)amineIBA 01/2024 - 04/2013
8	RNA (Ribonucleic Acid)IBA 01/2023 - 11/2010
6	EnzymesIBA 08/2023 - 11/2002
6	epidermal growth factor receptor VIIIIBA 01/2021 - 01/2013
6	AntibodiesIBA 10/2020 - 01/2013
6	Interleukin-2 (IL2)IBA 01/2018 - 01/2005
5	Interleukin-18 (Interleukin 18)IBA 05/2024 - 09/2008
5	InterferonsIBA 05/2024 - 11/2002
5	EpitopesIBA 10/2023 - 06/2012
5	B-Cell Maturation AntigenIBA 08/2023 - 01/2019
5	Peptides (Polypeptides)IBA 01/2021 - 01/2003
5	Cyclophosphamide (Cytoxan)FDA LinkGeneric 11/2019 - 05/2012
5	tocilizumab (atlizumab)FDA Link 01/2019 - 04/2013
4	ibrutinibIBA 11/2022 - 01/2016
4	Antiviral Agents (Antivirals)IBA 01/2022 - 11/2006
4	ChemokinesIBA 01/2022 - 06/2015
4	Sirolimus (Rapamycin)FDA Link 10/2015 - 08/2008
3	Monoclonal AntibodiesIBA 01/2023 - 10/2010
3	Biomarkers (Surrogate Marker)IBA 12/2022 - 01/2016
3	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2022 - 03/2005
3	DNA (Deoxyribonucleic Acid)IBA 11/2019 - 01/2002
3	Melphalan (Alkeran)FDA LinkGeneric 01/2019 - 09/2015
3	Interleukin-6 (Interleukin 6)IBA 01/2017 - 08/2015
3	Surface Antigens (Surface Antigen)IBA 01/2016 - 01/2014
3	Chemokine ReceptorsIBA 06/2015 - 07/2011
2	ErbB Receptors (EGF Receptor)IBA 02/2024 - 01/2021
2	Vancomycin FDA LinkGeneric 01/2023 - 01/2018
2	Cyclosporine (Ciclosporin)FDA LinkGeneric 01/2022 - 11/2006
2	Single-Domain AntibodiesIBA 11/2021 - 01/2020
2	blinatumomabIBA 11/2019 - 10/2016
2	Immune Checkpoint InhibitorsIBA 01/2019 - 12/2018
2	CTL019 chimeric antigen receptorIBA 12/2018 - 04/2013
2	Bevacizumab (Avastin)FDA Link 11/2018 - 01/2013
2	AutoantigensIBA 01/2018 - 01/2016

Therapy/Procedure

117	Therapeutics 05/2024 - 01/2002
80	Immunotherapy 02/2024 - 02/2002
17	Drug Therapy (Chemotherapy) 01/2023 - 01/2002
9	Cell- and Tissue-Based Therapy (Cell Therapy) 01/2022 - 01/2010
8	Stem Cell Transplantation 01/2019 - 02/2006
5	Hematopoietic Stem Cell Transplantation 01/2017 - 06/2010
4	Transplantation 12/2017 - 01/2011
3	Highly Active Antiretroviral Therapy (HAART) 01/2016 - 06/2002
3	Cell Transplantation 04/2013 - 09/2003
2	Radiotherapy 01/2018 - 07/2013